Manufacture of a GMP lot lentiviral vector CD22 car gene for clinical use

Ended Purchase Order Awarded Last action

Contract number
75N91018P00476
Awardee
Awarding agency
Obligated
$205,000

Award facts

Opportunity
Contract value 100% obligated
$205,000.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325414 Biological Product (except Diagnostic) Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Gaithersburg, MD 20878, USA

Award details come from SAM.gov/FPDS.

About this award

The National Cancer Institute issued a purchase order to Lentigen Technology, Inc. valued at $205,000 on August 31, 2018, for manufacture of a GMP lot lentiviral vector CD22 CAR gene for clinical use. Work is performed in Gaithersburg, Maryland. The order carries firm fixed price pricing with an ultimate completion date of August 30, 2019. The procurement originated from a pre-solicitation opportunity posted March 19, 2018, with a due date of April 2, 2018.

Quick answers

Who was awarded contract 75N91018P00476?

75N91018P00476 was awarded to Lentigen Technology, Inc. by National Cancer Institute (National Institutes of Health) on August 31, 2018.

How much is contract 75N91018P00476 worth?

The government has obligated $205,000 on 75N91018P00476.

Was contract 75N91018P00476 competed?

The extent of competition for 75N91018P00476 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award